Skip to main content
Erschienen in: Metabolic Brain Disease 6/2015

01.12.2015 | Original Article

Two novel compound heterozygous mutations in the BCKDHB gene that cause the intermittent form of maple syrup urine disease

verfasst von: Yi Guo, Liu Liming, Li Jiang

Erschienen in: Metabolic Brain Disease | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Intermittent maple syrup urine disease (MSUD) is a potentially life-threatening metabolic disorder caused by a deficiency of branched chain α-ketoacid dehydrogenase (BCKD) complex. In contrast to classic MSUD, children with the intermittent form usually have an atypical clinical manifestation. Here, we describe the presenting symptoms and clinical course of a Chinese boy with intermittent MSUD. Mutation analysis identified two previously unreported mutations in exon 7 of the BCKDHB gene: c.767A > G (p.Y256C) and c.768C > G (p.Y256X); the parents were each heterozygous for one of these mutations. In silico analysis predicted Y256C probably affects protein structure; Y256X leads to a premature stop codon. This case demonstrates intermittent MSUD should be suspected in cases with symptoms of recurrent encephalopathy, especially ataxia or marked drowsiness, which usually present after the neonatal period and in conjunction with infection. symmetrical basal ganglia damage but normal myelination in the posterior limb will assist differential diagnosis; alloisoleucine is a useful diagnostic marker and mutation analysis may be of prognostic value. These novel mutations Y256C and Y256X result in the clinical manifestation of a variant form of MSUD, expanding the mutation spectrum of this disease.
Literatur
Zurück zum Zitat Axler O, Holmquist P (2014) Intermittent maple syrup urine disease: two case reports. Pediatrics 133(2):e458–60CrossRefPubMed Axler O, Holmquist P (2014) Intermittent maple syrup urine disease: two case reports. Pediatrics 133(2):e458–60CrossRefPubMed
Zurück zum Zitat Bindu PS, Shehanaz KE, Christopher R, Pal PK, Ravishankar S (2007) Intermediate maple syrup urine disease: neuroimaging observations in 3 patients from South India. J Child Neurol 22(7):911–3CrossRefPubMed Bindu PS, Shehanaz KE, Christopher R, Pal PK, Ravishankar S (2007) Intermediate maple syrup urine disease: neuroimaging observations in 3 patients from South India. J Child Neurol 22(7):911–3CrossRefPubMed
Zurück zum Zitat Bindu PS, Kovoor JM, Christopher R (2010) Teaching NeuroImages: MRI in maple syrup urine disease. Neurology 74(3):516–524CrossRef Bindu PS, Kovoor JM, Christopher R (2010) Teaching NeuroImages: MRI in maple syrup urine disease. Neurology 74(3):516–524CrossRef
Zurück zum Zitat Hou JW, Hwang TL (2014) Different gene preferences of maple syrup urine disease in the aboriginal tribes of Taiwan. Pediatr Neonatol 55(3):213–7CrossRefPubMed Hou JW, Hwang TL (2014) Different gene preferences of maple syrup urine disease in the aboriginal tribes of Taiwan. Pediatr Neonatol 55(3):213–7CrossRefPubMed
Zurück zum Zitat Jaafar N, Moleirinho A, Kerkeni E et al (2013) Molecular characterization of maple syrup urine disease patients from Tunisia. Gene 517(1):116–119CrossRefPubMed Jaafar N, Moleirinho A, Kerkeni E et al (2013) Molecular characterization of maple syrup urine disease patients from Tunisia. Gene 517(1):116–119CrossRefPubMed
Zurück zum Zitat Kilicarslan R, Alkan A, Demirkol D et al (2012) Maple syrup urine disease: diffusion-weighted MRI findings during acute metabolic encephalopathic crisis. Jpn J Radiol 30(6):522–525CrossRefPubMed Kilicarslan R, Alkan A, Demirkol D et al (2012) Maple syrup urine disease: diffusion-weighted MRI findings during acute metabolic encephalopathic crisis. Jpn J Radiol 30(6):522–525CrossRefPubMed
Zurück zum Zitat Schadewaldt P, Bodner-Leidecker A, Hammen HW et al (1999) Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease. Clin Chem 45(10):1734–1740PubMed Schadewaldt P, Bodner-Leidecker A, Hammen HW et al (1999) Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease. Clin Chem 45(10):1734–1740PubMed
Zurück zum Zitat Strauss KA, Morton DH (2003) Branched-chain ketoacyl dehydrogenase deficiency: maple syrup disease. Curr Treat Options Neurol 5:329–341CrossRefPubMed Strauss KA, Morton DH (2003) Branched-chain ketoacyl dehydrogenase deficiency: maple syrup disease. Curr Treat Options Neurol 5:329–341CrossRefPubMed
Zurück zum Zitat Strauss KA, Puffenberger EG, Morton DH (1993) Maple syrup urine disease. In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP (eds) eneReviews™. University of Washington, Seattle Strauss KA, Puffenberger EG, Morton DH (1993) Maple syrup urine disease. In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP (eds) eneReviews™. University of Washington, Seattle
Zurück zum Zitat Wang YP, Qi ML, Li TT, Zhao YJ (2012) Two novel mutations in the BCKDHB gene (R170H, Q346R) cause the classic form of maple syrup urine disease (MSUD). Gene 498(1):112–5CrossRefPubMed Wang YP, Qi ML, Li TT, Zhao YJ (2012) Two novel mutations in the BCKDHB gene (R170H, Q346R) cause the classic form of maple syrup urine disease (MSUD). Gene 498(1):112–5CrossRefPubMed
Zurück zum Zitat Wynn RM, Machius M, Chuang JL, Li J, Tomchick DR, Chuang DT (2003) Roles of His291-αand His146-βin the reductive acylation reaction catalyzed by human ranched-chain α-ketoacid dehydrogenase: refined phosphorylation loop structure in the active site. J Biol Chem 278:43402–43410CrossRefPubMed Wynn RM, Machius M, Chuang JL, Li J, Tomchick DR, Chuang DT (2003) Roles of His291-αand His146-βin the reductive acylation reaction catalyzed by human ranched-chain α-ketoacid dehydrogenase: refined phosphorylation loop structure in the active site. J Biol Chem 278:43402–43410CrossRefPubMed
Zurück zum Zitat Yang N, Han L, Gu X et al (2012) Analysis of gene mutations in Chinese patients with maple syrup urine disease. Mol Genet Metab 106(4):412–418CrossRefPubMed Yang N, Han L, Gu X et al (2012) Analysis of gene mutations in Chinese patients with maple syrup urine disease. Mol Genet Metab 106(4):412–418CrossRefPubMed
Zurück zum Zitat Zhao Y, Hawes J, Popov KM, Jaskiewicz J, Shimomura Y, Crabb DW, Harris RA (1994) Site-directed mutagenesis of phosphorylation sites of the branched chainα-ketoacid ehydrogenase complex. J Biol Chem 269:18583–18587PubMed Zhao Y, Hawes J, Popov KM, Jaskiewicz J, Shimomura Y, Crabb DW, Harris RA (1994) Site-directed mutagenesis of phosphorylation sites of the branched chainα-ketoacid ehydrogenase complex. J Biol Chem 269:18583–18587PubMed
Zurück zum Zitat Zinnanti WJ, Lazovic J, Griffin K et al (2009) Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain 132(4):903–918PubMedCentralCrossRefPubMed Zinnanti WJ, Lazovic J, Griffin K et al (2009) Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain 132(4):903–918PubMedCentralCrossRefPubMed
Metadaten
Titel
Two novel compound heterozygous mutations in the BCKDHB gene that cause the intermittent form of maple syrup urine disease
verfasst von
Yi Guo
Liu Liming
Li Jiang
Publikationsdatum
01.12.2015
Verlag
Springer US
Erschienen in
Metabolic Brain Disease / Ausgabe 6/2015
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-015-9711-z

Weitere Artikel der Ausgabe 6/2015

Metabolic Brain Disease 6/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.